National Microbiology Framework - Lot 1: Diagnostic Goods and Services
A Contract Award Notice
by PUBLIC HEALTH ENGLAND
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- 4 year (est.)
- Value
- £3B
- Sector
- HEALTH
- Published
- 16 Apr 2021
- Delivery
- To 24 Apr 2025 (est.)
- Deadline
- n/a
Concepts
Location
United Kingdom:
1 buyer
- Public Health England London
112 suppliers
- Mornington 2000LLP Harrogate
- Amenarini Diagnostics Wokingham
- Ab Molecular Buckingham
- Ab Scientific London
- Abbott Laboratories Maidenhead
- Abbott Rapid Diagnostics Stockport
- Aeskuuk London
- Agena Bioscience Hamburg
- Alpha Laboratories Eastleigh
- Altona Diagnostics Liverpool
- Appleton Woods Birmingham
- Ausdiagnostics Chesham
- Alphabiolaboratories Analytical Warrington
- Beckman Coulter High Wycombe
- Becton Dickinson Wokingham
- Bgi Genomics London
- Bioconnections Wetherby
- Eurofins Biomnis Hampshire
- Biomérieux Basingstoke
- Bio Rad Laboratories Watford
- Bioserv Cambridge
- Biosure Essex
- Bruker Coventry
- Cambridge Bioscience Cambridge
- Cambridge Life Sciences Ely
- Cepheid Wooburn Green
- Chase Madison Birmingham
- Cerescom London
- Chirus Watford
- Connect2Pharma Croydon
- Diasorin Blewbury
- Dnanudge London
- Don Whitley Scientific Bingley
- Elitech Milton Keynes
- Euroimmun London
- Europlaz Technologies Essex
- Excalibur Healthcare Services London
- Genedrive Diagnostics Manchester
- Genefirst Abingdon
- Genetic Signatures Haywards Heath
- Greiner Bio One Stonehouse
- Grifols London
- Healthlinked Bathgate
- Hologic Wythenshawe
- Horiba Northampton
- Idvet Grabels
- Illumina Cambridge Great Abington
- Intertek Testing & Certification Essex
- Immensa Health Clinic London
- Hymon Cumbria
- Invitech Huntingdon
- Labmediaservis Sro Jaroměř
- Launch Diagnostics Reading
- Seracare Life Sciences Inc Dba LGC Clinical Diagnostics Milford
- Life Technologies Paisley
- Luminex Corporation Texas
- Lumiradx London
- Malvern Medical Developments Worcester
- Mast Group Bootle
- Medical Wire & Equipment Co Bath Corsham
- Medline Scientific Oxford
- Medusa19 Healthcare Manchester
- Mgi International Sales Shek Mun
- Microgen Bioproducts Camberley
- Mobidiag Slough
- Multiplexdx Sro Bratislava
- Nal Von Minden Moers
- Optigene Horsham
- Origin Packaging North Ferriby
- Ortho Clinical Diagnostics Bridgend
- Oscartech London
- Oxford Biosystems Abingdon
- Oxford Immunotec Abingdon
- Oxford Nanopore Diagnostics Oxford
- Pathway Diagnostics Limpsfield
- Perkinelmer LAS Beaconsfield
- Primer Design Camberley
- Pro Lab Diagnostics Wirral
- Promega Southampton
- Qiagen Manchester
- Quantumdx Group Newcastle upon Tyne
- Quidel Ireland Galway
- Randox Laboratories Crumlin
- Rapid Labs Ipswich
- R Biopharm Rhone London
- Roche Diagnostics Burgess Hill
- Rta Laboratuvarlari Kocaeli
- Scientific Laboratory Supplies Hessle
- Serosep Crawley
- Siemens Healthcare Diagnostics Camberley
- Speedx London
- SPT Labtech Melbourn
- Stratech Scientific Ely
- Surescreen Diagnostics Derby
- Sysmex Milton Keynes
- Tanner Pharma St Albans
- Tecan Theale
- Techno Path Distribution Ballina
- Teva Castleford
- Binding Site Group Birmingham
- Thermo Fisher Diagnostics Altrincham
- Thermofisher Scientific Newport
- TMC Worldnetwork London
- Ukos Hemel Hempstead
- Una Health Stoke on Trent
- Vectornate Hampton
- V H Bio Gateshead
- VWR Lutterworth
- Werfen Warrington
- Wolf Laboratories York
- Wuhan Healthcare Biotechnology Wuhan
- Yourgene Health Manchester
Description
Lot 1 – Diagnostic Goods and Services is for the supply of in vitro diagnostic medical devices and associated services including equipment, consumables, maintenance, and peripheral equipment and associated services. All reagents and consumables comply with current CE regulations (UKCA regulations when applicable) and must retain the CE mark (or, once superseded, the UKCA mark) for the duration of the Framework and any potential extensions. This Lot includes provisions for reagent rental and managed equipment services. Please note that this Award Notice is for Lot 1, however the Framework Agreement encompasses the following four lots: - Lot 1: Diagnostic Goods and Services - Lot 2: Research and Development Goods and Services - Lot 3: Manufacturing, Product Development and Commercialisation - Lot 4: Clinical Laboratory Diagnostic Testing Services
Total Quantity or Scope
The Framework Agreement relates to the supply of diagnostics Goods for the qualitative / quantitative examination of specimens / samples and the development or manufacturing of assays / kits / medication and related Services. It also relates to the supply of diagnostics Services for the qualitative / quantitative examination of specimens / samples or the development or manufacturing of assays / kits / medication. The framework also covers Clinical Laboratory Diagnostic Testing Services. The term of the framework will be for an initial 2 years with options to extend by up to a further 2 years. Additional information: The value attributed to each Lot is an approximate estimate only. As indicated in Section VI.3. of this Notice, the actual values will be to such level as those purchasing under the Framework Agreement consider necessary to provide suitable requirements.
Award Detail
1 | Mornington 2000LLP (Harrogate)
|
2 | Amenarini Diagnostics (Wokingham)
|
3 | Ab Molecular (Buckingham)
|
4 | Ab Scientific (London)
|
5 | Abbott Laboratories (Maidenhead)
|
6 | Abbott Rapid Diagnostics (Stockport)
|
7 | Aeskuuk (London)
|
8 | Agena Bioscience (Hamburg)
|
9 | Alpha Laboratories (Eastleigh)
|
10 | Altona Diagnostics (Liverpool)
|
11 | Appleton Woods (Birmingham)
|
12 | Ausdiagnostics (Chesham)
|
13 | Alphabiolaboratories Analytical (Warrington)
|
14 | Beckman Coulter (High Wycombe)
|
15 | Becton Dickinson (Wokingham)
|
16 | Bgi Genomics (London)
|
17 | Bioconnections (Wetherby)
|
18 | Eurofins Biomnis (Hampshire)
|
19 | Biomérieux (Basingstoke)
|
20 | Bio Rad Laboratories (Watford)
|
21 | Bioserv (Cambridge)
|
22 | Biosure (Essex)
|
23 | Bruker (Coventry)
|
24 | Cambridge Bioscience (Cambridge)
|
25 | Cambridge Life Sciences (Ely)
|
26 | Cepheid (Wooburn Green)
|
27 | Chase Madison (Birmingham)
|
28 | Cerescom (London)
|
29 | Chirus (Watford)
|
30 | Connect2Pharma (Croydon)
|
31 | Diasorin (Blewbury)
|
32 | Dnanudge (London)
|
33 | Don Whitley Scientific (Bingley)
|
34 | Elitech (Milton Keynes)
|
35 | Euroimmun (London)
|
36 | Europlaz Technologies (Essex)
|
37 | Excalibur Healthcare Services (London)
|
38 | Genedrive Diagnostics (Manchester)
|
39 | Genefirst (Abingdon)
|
40 | Genetic Signatures (Haywards Heath)
|
41 | Greiner Bio One (Stonehouse)
|
42 | Grifols (London)
|
43 | Healthlinked (Bathgate)
|
44 | Hologic (Wythenshawe)
|
45 | Horiba (Northampton)
|
46 | Idvet (Grabels)
|
47 | Illumina Cambridge (Great Abington)
|
48 | Intertek Testing & Certification (Essex)
|
49 | Immensa Health Clinic (London)
|
50 | Hymon (Cumbria)
|
51 | Invitech (Huntingdon)
|
52 | Labmediaservis Sro (Jaroměř)
|
53 | Launch Diagnostics (Reading)
|
54 | Seracare Life Sciences Inc Dba LGC Clinical Diagnostics (Milford)
|
55 | Life Technologies (Paisley)
|
56 | Luminex Corporation (Texas)
|
57 | Lumiradx (London)
|
58 | Malvern Medical Developments (Worcester)
|
59 | Mast Group (Bootle)
|
60 | Medical Wire & Equipment Co Bath (Corsham)
|
61 | Medline Scientific (Oxford)
|
62 | Medusa19 Healthcare (Manchester)
|
63 | Mgi International Sales (Shek Mun)
|
64 | Microgen Bioproducts (Camberley)
|
65 | Mobidiag (Slough)
|
66 | Multiplexdx Sro (Bratislava)
|
67 | Nal Von Minden (Moers)
|
68 | Optigene (Horsham)
|
69 | Origin Packaging (North Ferriby)
|
70 | Ortho Clinical Diagnostics (Bridgend)
|
71 | Oscartech (London)
|
72 | Oxford Biosystems (Abingdon)
|
73 | Oxford Immunotec (Abingdon)
|
74 | Oxford Nanopore Diagnostics (Oxford)
|
75 | Pathway Diagnostics (Limpsfield)
|
76 | Perkinelmer LAS (Beaconsfield)
|
77 | Primer Design (Camberley)
|
78 | Pro Lab Diagnostics (Wirral)
|
79 | Promega (Southampton)
|
80 | Qiagen (Manchester)
|
81 | Quantumdx Group (Newcastle upon Tyne)
|
82 | Quidel Ireland (Galway)
|
83 | Randox Laboratories (Crumlin)
|
84 | Rapid Labs (Ipswich)
|
85 | R Biopharm Rhone (London)
|
86 | Roche Diagnostics (Burgess Hill)
|
87 | Rta Laboratuvarlari (Kocaeli)
|
88 | Scientific Laboratory Supplies (Hessle)
|
89 | Serosep (Crawley)
|
90 | Siemens Healthcare Diagnostics (Camberley)
|
91 | Speedx (London)
|
92 | SPT Labtech (Melbourn)
|
93 | Stratech Scientific (Ely)
|
94 | Surescreen Diagnostics (Derby)
|
95 | Sysmex (Milton Keynes)
|
96 | Tanner Pharma (St Albans)
|
97 | Tecan (Theale)
|
98 | Techno Path Distribution (Ballina)
|
99 | Teva (Castleford)
|
100 | Binding Site Group (Birmingham)
|
101 | Thermo Fisher Diagnostics (Altrincham)
|
102 | Thermofisher Scientific (Newport)
|
103 | TMC Worldnetwork (London)
|
104 | Ukos (Hemel Hempstead)
|
105 | Una Health (Stoke on Trent)
|
106 | Vectornate (Hampton)
|
107 | V H Bio (Gateshead)
|
108 | VWR (Lutterworth)
|
109 | Werfen (Warrington)
|
110 | Wolf Laboratories (York)
|
111 | Wuhan Healthcare Biotechnology (Wuhan)
|
112 | Yourgene Health (Manchester)
|
Renewal Options
The framework agreement will be for an initial period of 24 months with options exercisable by the Authority under the framework agreement to extend the duration in increments by up to a maximum of 24 months. Therefore, the total maximum duration of the framework agreement is 48 months. The Authority will also have the option to purchase new and/or updated Goods and/or Services which the Supplier proposes should be added to its range as described in Section VI.3 below.
Award Criteria
price | _ |
CPV Codes
- 33000000 - Medical equipments, pharmaceuticals and personal care products
Indicators
- Options are available.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** The framework is intended to be accessed by: Public Health England; Department of Health and Social Care; Public Health Wales; Public Health Scotland; Department for Health for Northern Ireland; Health and Social Care Northern Ireland; NHS Authorities, NHS Trusts, NHS Foundation Trusts, Special Health Authorities, NHS Scotland Health Boards, NHS Wales Health Boards, NHS Northern Ireland Health Boards, Special NHS Boards and any other NHS entity; Local Authorities; any other bodies governed by public law (as defined in regulation 2 of the Public Contracts Regulations 2015 (SI 2015/102) (as amended); and academic or charitable institutions (including any such institutions that are not Contracting Authorities). Examples of such bodies can be found at the following links (as of date of publication): https://www.gov.uk/government/organisations/charity-commission https://www.nhs.uk/servicedirectories/pages/nhstrustlisting.aspx The framework value is an approximate estimate only. The actual values will be to such level as those purchasing under the Framework Agreement consider necessary to provide suitable requirements. PHE works with DHSC and the NHS in its role as a national and international emergency responder to current and emerging threats to public health. As demonstrated by the COVID-19 pandemic, the exact nature, timing and escalation of such threats (and the corresponding required responses) can be difficult to foresee, making any exercise in future value estimation unpredictable. The scope of this Framework Agreement covers Goods and Services that are subject to rapid and frequent improvements, advancements and new scientific and technical developments. Therefore, to keep this Framework Agreement in line with the latest market and scientific developments so as to ensure that patients and other end users have ongoing access to state of the art diagnostics for the duration of this Framework Agreement successful Suppliers will be able to propose new and/or updated Goods and/or Services to be added to a Supplier’s range under the Framework Agreement if one or more of the following circumstances apply: • Where the proposed updated Goods or Services fall within the general scope of this procurement as set out as part of this OJEU Contract Notice (i.e. fall within an existing main or supplementary CPV code as may be referred to in this Contract Notice and/or the description sections of this Contract Notice); • Where the proposed new Goods or Services fall within the broad categories of Goods or Services covered by this Framework Agreement (i.e. fall within an existing main or supplementary CPV code as may be referred to in this Contract Notice and/or the broad categories of Goods and/or Services referred to in any of the description sections of this Contract Notice), but are new to the market. For the avoidance of doubt, for the purposes of any testing services, this will allow Suppliers to offer new types of tests, new test kits, related new equipment / products, related new consumables and related new Services as and when they become available during the duration of the Framework Agreement provided they fall within an existing main or supplementary CPV code as may be referred to in this Contract Notice and/or the broad categories of Goods and/or Services referred to in any of the description sections of this Contract Notice); • Where the proposed new or updated Goods or Services reflect a product or service line extension (i.e. are new, modified or updated products or services in the same category of Goods or Services already supplied by a Supplier under this Framework Agreement); or • Where the proposed new or updated Goods or Services reflect a range extension (i.e. are new, modified or updated products or services that reflect an expansion of the Supplier’s range in the same category of Goods or Services already supplied by a Supplier under this Framework Agreement).
Reference
- ocds-h6vhtk-02a73a
- FTS 008137-2021